Akoya Biosciences, Inc. Q4 Loss Decreases, But Misses Estimates

Akoya Biosciences, Inc. (AKYA) revealed Loss for fourth quarter that decreased from the same period last year but missed the Street estimates.

The company's bottom line came in at -$8.20 million, or -$0.17 per share. This compares with -$10.80 million, or -$0.22 per share, last year.

Analysts on average had expected the company to earn -$0.16 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period fell 19.4% to $21.34 million from $26.49 million last year.

Akoya Biosciences, Inc. earnings at a glance (GAAP) :

-Earnings: -$8.20 Mln. vs. -$10.80 Mln. last year.
-EPS: -$0.17 vs. -$0.22 last year.
-Revenue: $21.34 Mln vs. $26.49 Mln last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com